对吲哚美辛加去氨加压素治疗有效的肾性尿崩症 - Suppr

Suppr

超能文献

Nephrogenic diabetes insipidus responsive to indomethacin plus dDAVP.

作者信息

Stasior D S, Kikeri D, Duel B, Seifter J L

出版信息

N Engl J Med. 1991 Mar 21;324(12):850-1. doi: 10.1056/nejm199103213241215.

DOI:10.1056/nejm199103213241215

PMID:1997862

Abstract

摘要

相似文献

Nephrogenic diabetes insipidus responsive to indomethacin plus dDAVP.对吲哚美辛加去氨加压素治疗有效的肾性尿崩症

N Engl J Med. 1991 Mar 21;324(12):850-1. doi: 10.1056/nejm199103213241215.

Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate.去氨加压素和吲哚美辛治疗接受碳酸锂治疗患者的肾性尿崩症

South Med J. 1990 Dec;83(12):1475-7. doi: 10.1097/00007611-199012000-00026.

Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.肾性尿崩症中因子VIII和血管性血友病因子对1-去氨基-8-D-精氨酸加压素的正常反应。

J Clin Endocrinol Metab. 1988 Jul;67(1):191-3. doi: 10.1210/jcem-67-1-191.

Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.由肾性尿崩症导致的显著低渗性多尿，对血管加压素有部分敏感性。

J Clin Endocrinol Metab. 1984 Dec;59(6):1044-9. doi: 10.1210/jcem-59-6-1044.

Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.先天性肾性尿崩症患者对1-去氨基[8-D-精氨酸]血管加压素的血流动力学和凝血反应。

N Engl J Med. 1988 Apr 7;318(14):881-7. doi: 10.1056/NEJM198804073181403.

Management of diabetes insipidus with DDAVP.使用去氨加压素治疗尿崩症。

J Pediatr. 1978 Nov;93(5):896-7. doi: 10.1016/s0022-3476(78)81126-3.

Management of cranial diabetes insipidus with oral desmopressin (DDAVP).口服去氨加压素（DDAVP）治疗颅咽管瘤性尿崩症

Clin Endocrinol (Oxf). 1986 Mar;24(3):253-7. doi: 10.1111/j.1365-2265.1986.tb03265.x.

Allergic reaction to DDAVP in diabetes insipidus: successful treatment with its graded doses.尿崩症患者对去氨加压素的过敏反应：分次剂量治疗成功

Endocrinol Jpn. 1982 Aug;29(4):475-7. doi: 10.1507/endocrj1954.29.475.

DDAVP in the treatment of central diabetes insipidus.去氨加压素治疗中枢性尿崩症

N Engl J Med. 1976 Mar 4;294(10):507-11. doi: 10.1056/NEJM197603042941001.

[Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].[去氨加压素（1-去氨基-8-D-精氨酸加压素），一种新型合成加压素类似物，治疗儿童尿崩症的临床经验]

Pediatrie. 1975 Apr-May;30(3):265-270.

引用本文的文献

Central and nephrogenic diabetes insipidus: updates on diagnosis and management.中枢性和肾性尿崩症：诊断与管理的最新进展

Front Endocrinol (Lausanne). 2025 Jan 8;15:1479764. doi: 10.3389/fendo.2024.1479764. eCollection 2024.

Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.锂致肾性尿崩症合并噻嗪类利尿剂和非甾体抗炎药治疗有效：病例报告并文献复习。

Intern Med. 2024 May 15;63(10):1399-1404. doi: 10.2169/internalmedicine.2437-23. Epub 2023 Sep 29.

Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin.异环磷酰胺诱导的肾性尿崩症对超生理剂量静脉注射去氨加压素有效。

Clin Nephrol Case Stud. 2021 Jul 1;9:87-92. doi: 10.5414/CNCS110589. eCollection 2021.

Lithium Chloride and GSK3 Inhibition Reduce Aquaporin-2 Expression in Primary Cultured Inner Medullary Collecting Duct Cells Due to Independent Mechanisms.氯化锂和 GSK3 抑制通过独立的机制减少原代培养的内髓集合管细胞中水通道蛋白-2 的表达。

Cells. 2020 Apr 23;9(4):1060. doi: 10.3390/cells9041060.

LITHIUM-INDUCED NEPHROGENIC DIABETES INSIPIDUS RESPONSIVE TO DESMOPRESSIN.锂诱导的肾性尿崩症对去氨加压素有效。

Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):270-271. doi: 10.4183/aeb.2019.270.

Partial nephrogenic diabetes insipidus associated with lithium therapy.与锂盐治疗相关的部分性肾性尿崩症

BMJ Case Rep. 2019 Sep 6;12(9):e231093. doi: 10.1136/bcr-2019-231093.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验